September 2017 which has been reviewed by auditor are as follows: Table1: Financial Summary for the three-month period of year 2016 and 2017 Unit: Million Baht Q3’2017 Q3’2016 Increase (Decrease) % Change

Company Limited (the “Company”) Board of Meeting No.1/2018 on 22 February 2018, the resolution to certify the Company’s financial statements and performance for the yearly ending 31 December 2017 which has

% Analysis of Financial Statement of Position As of 31 Dec 16 As of 31 Dec 17 Change MB % MB % MB % Cash and cash equivalents 111.0 2.7% 513.4 9.8% 402.4 362.4% Current portion of loans receivable from

: Million Baht 2018 2017 Change Amount % Amount % Amount % Revenues from dental service 456.15 96.64 386.72 98.70 69.43 17.95 Other revenues 15.88 3.36 5.11 1.30 10.77 210.63 Total revenues from medical

Q2/2020 (Ending June 30, 2020) To Director and Manager of the Stock Exchange of Thailand UBIS (Asia) Public Company Limited (“the Company”) would like to clarify on the performance and the financial

(Ending March 31, 2020) To Director and Manager of the Stock Exchange of Thailand Ubis (Asia) Public Company Limited (“the Company”) would like to clarify on the performance and the financial status for the

’ Meeting No. 6/2018, held on September 7, 2018 and details of which are disclosed in notes No. 11 of the Company’ s consolidated financial statements for nine months ended September 30, 2018, and the

. The change had effect to the financial statements. Therefore, deferred tax for the year 2014 to 2016 were Baht 4.75 million, Baht 1.29 million and Baht 1.27 million respectively.  The Company got

financial statements of foreign operations rose by Baht 5,459 million. Contingent Liabilities Million Baht Item September 2019 June 2019 December 2018 Change (%) June 2019 December 2018 Avals to bills 7,259

interests (1) (6) (6) (88%) Profit (loss) for the period (255) 214 (469) (219%) Financial Summary Income Statement (million baht) Quater 1/2020 Quater 1/2019 Increase (Decrease) % Change The Company’s Net